393 related articles for article (PubMed ID: 16179649)
1. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription.
Christensen J; Cloos P; Toftegaard U; Klinkenberg D; Bracken AP; Trinh E; Heeran M; Di Stefano L; Helin K
Nucleic Acids Res; 2005; 33(17):5458-70. PubMed ID: 16179649
[TBL] [Abstract][Full Text] [Related]
2. E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes.
Di Stefano L; Jensen MR; Helin K
EMBO J; 2003 Dec; 22(23):6289-98. PubMed ID: 14633988
[TBL] [Abstract][Full Text] [Related]
3. E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription.
Cartwright P; Müller H; Wagener C; Holm K; Helin K
Oncogene; 1998 Aug; 17(5):611-23. PubMed ID: 9704927
[TBL] [Abstract][Full Text] [Related]
4. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
Rotheneder H; Geymayer S; Haidweger E
J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
[TBL] [Abstract][Full Text] [Related]
5. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
Araki K; Nakajima Y; Eto K; Ikeda MA
Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
[TBL] [Abstract][Full Text] [Related]
6. A new member of the DP family, DP-3, with distinct protein products suggests a regulatory role for alternative splicing in the cell cycle transcription factor DRTF1/E2F.
Ormondroyd E; de la Luna S; La Thangue NB
Oncogene; 1995 Oct; 11(8):1437-46. PubMed ID: 7478568
[TBL] [Abstract][Full Text] [Related]
7. Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F.
Ohtani K; Iwanaga R; Nakamura M; Ikeda M; Yabuta N; Tsuruga H; Nojima H
Oncogene; 1999 Apr; 18(14):2299-309. PubMed ID: 10327050
[TBL] [Abstract][Full Text] [Related]
8. Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1.
Darbinian N; Gallia GL; Kundu M; Shcherbik N; Tretiakova A; Giordano A; Khalili K
Oncogene; 1999 Nov; 18(46):6398-402. PubMed ID: 10597240
[TBL] [Abstract][Full Text] [Related]
9. Role of pRB-family/E2F complex in the inhibition of IL-3-dependent lymphoid cell proliferation.
Yamada M; Kondo T; Ashizawa S; Takebayashi T; Higashi H; Hatakeyama M
Cytokine; 2002 Jan; 17(2):91-7. PubMed ID: 11886176
[TBL] [Abstract][Full Text] [Related]
10. The transcriptional repressor gene Mad3 is a novel target for regulation by E2F1.
Fox EJ; Wright SC
Biochem J; 2003 Feb; 370(Pt 1):307-13. PubMed ID: 12444919
[TBL] [Abstract][Full Text] [Related]
11. Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex.
Le Cam L; Polanowska J; Fabbrizio E; Olivier M; Philips A; Ng Eaton E; Classon M; Geng Y; Sardet C
EMBO J; 1999 Apr; 18(7):1878-90. PubMed ID: 10202151
[TBL] [Abstract][Full Text] [Related]
12. Cloning and characterization of human DP2, a novel dimerization partner of E2F.
Zhang Y; Chellappan SP
Oncogene; 1995 Jun; 10(11):2085-93. PubMed ID: 7784053
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of mammalian cell proliferation by genetically selected peptide aptamers that functionally antagonize E2F activity.
Fabbrizio E; Le Cam L; Polanowska J; Kaczorek M; Lamb N; Brent R; Sardet C
Oncogene; 1999 Jul; 18(30):4357-63. PubMed ID: 10439043
[TBL] [Abstract][Full Text] [Related]
14. Interaction between the pura and E2F-1 transcription factors.
Darbinian N; White MK; Gallia GL; Amini S; Rappaport J; Khalili K
Anticancer Res; 2004; 24(5A):2585-94. PubMed ID: 15517862
[TBL] [Abstract][Full Text] [Related]
15. RBP1 induces growth arrest by repression of E2F-dependent transcription.
Lai A; Marcellus RC; Corbeil HB; Branton PE
Oncogene; 1999 Mar; 18(12):2091-100. PubMed ID: 10321733
[TBL] [Abstract][Full Text] [Related]
16. Integration of a growth-suppressing BTB/POZ domain protein with the DP component of the E2F transcription factor.
de la Luna S; Allen KE; Mason SL; La Thangue NB
EMBO J; 1999 Jan; 18(1):212-28. PubMed ID: 9878064
[TBL] [Abstract][Full Text] [Related]
17. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.
Alvaro-Blanco J; Martínez-Gac L; Calonge E; Rodríguez-Martínez M; Molina-Privado I; Redondo JM; Alcamí J; Flemington EK; Campanero MR
Carcinogenesis; 2009 Mar; 30(3):440-8. PubMed ID: 19126644
[TBL] [Abstract][Full Text] [Related]
18. Computer-assisted identification of cell cycle-related genes: new targets for E2F transcription factors.
Kel AE; Kel-Margoulis OV; Farnham PJ; Bartley SM; Wingender E; Zhang MQ
J Mol Biol; 2001 May; 309(1):99-120. PubMed ID: 11491305
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase.
Wells J; Yan PS; Cechvala M; Huang T; Farnham PJ
Oncogene; 2003 Mar; 22(10):1445-60. PubMed ID: 12629508
[TBL] [Abstract][Full Text] [Related]
20. PARP-1 binds E2F-1 independently of its DNA binding and catalytic domains, and acts as a novel coactivator of E2F-1-mediated transcription during re-entry of quiescent cells into S phase.
Simbulan-Rosenthal CM; Rosenthal DS; Luo R; Samara R; Espinoza LA; Hassa PO; Hottiger MO; Smulson ME
Oncogene; 2003 Nov; 22(52):8460-71. PubMed ID: 14627987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
